Pneumoproteins as markers of paraquat lung injury: A clinical case

Journal of Forensic and Legal Medicine

Volumn 15, Issue 1, 2008, Pages 48-52

  Hantson, Philippe ^a   Weynand, Birgit ^a   Doyle, Ian ^a   Bernand, Alfred ^a   Hermans, Cedric ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Acute lung injury; Clara cell 16 kDa protein; Paraquat; Surfactant associated proteins A and B

Indexed keywords

ACETYLCYSTEINE; CLARA CELL PROTEIN; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; OXYGEN; PARAQUAT; SECRETORY PROTEIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B;

ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; AUTOPSY; BODY FLUID; CASE REPORT; CAUSE OF DEATH; FATALITY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; INGESTION; INTOXICATION; KIDNEY CLEARANCE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LUNG GAS EXCHANGE; LUNG LAVAGE; LUNG PARENCHYMA; MALE; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PROTEIN BLOOD LEVEL; SUICIDE; TISSUE SPECIFICITY;

ADULT; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CREATININE; CYSTATINS; FORENSIC PATHOLOGY; FORENSIC TOXICOLOGY; HERBICIDES; HUMANS; KIDNEY FAILURE, ACUTE; LUNG; MALE; PARAQUAT; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; UTEROGLOBIN;

EID: 37149011104     PISSN: 1752928X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcfm.2006.09.003     Document Type: Article

References (28)

1. Bismuth C., Hall A.H., and Wong A. Paraquat ingestion exposure: symptomatology and risk. In: Bismuth C., and Hall A.H. (Eds). Paraquat poisoning: mechanisms-prevention-treatment (1995), Marcel Dekker, New York (NY) 195-210
2. Sato S. Human paraquat toxicology: prognostic factors. In: Bismuth C., and Hall A.H. (Eds). Paraquat poisoning: mechanisms-prevention-treatment (1995), Marcel Dekker, New York, NY 267-274
3. Suzuki K., Takasu N., Arita S., Maenosono A., Ishimatsu S., Nishina M., et al. A new method for predicting the outcome and survival period in paraquat poisoning. Hum Toxicol 8 (1989) 33-38
4. Hermans C., and Bernard A. Lung epithelium specific proteins: characteristics and potential applications as markers. State of the art. Am J Respir Crit Care Med 159 (1999) 646-678
5. Hermans C., and Bernard A. Pneumoproteinemia: a new perspective in the assessment of lung disorders. Eur Respir J 11 (1998) 801-803
6. Doyle I.R., Hermans C., Bernard A., Nicholas T.E., and Bersten A.D. Clearance of Clara cell secretory protein (CC16) and surfactant proteins A and B from blood in acute respiratory failure. Am J Respir Crit Care Med 158 (1998) 1528-1535
7. Rose M.S., Smith L.L., and Wyatt I. Evidence for energy-dependent accumulation of paraquat into rat lung. Nature 252 (1974) 314-315
8. Bernard A., Dumont X., Roels H., Lauwerys R., Dierynck I., De Ley M., et al. The molecular mass and concentrations of protein 1 or Clara cell protein in biological fluids: a reappraisal. Clin Chim Acta 223 (1993) 189-191
9. Itoh Y., Ishii S., Okutani R., Asano Y., and Kawai T. Protein 1: its purification and application in clinical medicine. J Clin Lab Anal 7 (1993) 394-400
10. Shijubo N., Itoh Y., Yamaguchi T., Shibuya Y., Morita Y., Hirasawa M., et al. Serum and BAL Clara cell 10 kDa protein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers. Eur Respir J 10 (1997) 1108-1114
11. Bernard A., Marchandise F.X., Depelchin S., Lauwerys R., and Sibille Y. Clara cell protein in serum and bronchoalveolar lavage. Eur Respir J 5 (1992) 1231-1238
12. Lesur O., Bernard A., Arsalane K., Lauwerys R., Begin R., Cantin A., et al. Clara cell protein (CC16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am J Respir Crit Care Med 152 (1995) 290-297
13. Jorens P.G., Sibille Y., Goulding N.J., van Overveld F.J., Herman A.G., Bossaert L., et al. Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury. Eur Respir J 8 (1995) 1647-1653
14. Hermans C., Knoops B., Wiedig M., Arsalane K., Toubeau G., Falmagne P., et al. Clara cell protein (CC16) in experimental lung injury: assessment as marker of Clara cell damage and bronchoalveolar blood barrier permeability. Eur Respir J 13 (1999) 1014-1021
15. Hermans C., Osman A., Nyberg B.I., Peterson C., and Bernard A. Determinants of Clara cell protein (CC16) concentration in serum: a reassessment with two different immunoassays. Clin Chim Acta 272 (1998) 101-110
16. Bernard A., Thielemans N., Lauwerys R., Vandeleene B., and Lambert A.E. The renal handling of protein 1 (Clara cell protein): effect of age, sex, and renal dysfunction. Contrib Nephrol 101 (1993) 66-70
17. Kabanda A., Goffin E., Bernard A., Lauwerys R., and van Ypersele de Strihou C. Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis. Kidney Int 48 (1995) 1946-1952
18. Gregory T.J., Longmore W.J., Moxley M.A., Whitsett J.A., Reed C.R., Fowler A.A., et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88 (1991) 1976-1981
19. Gunther A., Siebert C., Schmidt R., Ziegler S., Grimminger F., Yabut M., et al. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 153 (1996) 176-184
20. Greene K.E., Wright J.R., Steinberg K.P., Ruzinski J.T., Caldwell E., Wong W.B., et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 160 (1999) 1843-1850
21. Veldhuizen R.A., McCaig L.A., Akino T., and Lewis J.F. Pulmonary surfactant subfractions in patients with the acute respiratory syndrome. Am J Respir Crit Care Med 152 (1995) 1867-1871
22. Phielps D.S., Umstead T.M., Mejia M., Carrillo G., Pardo A., and Selman M. Increased surfactant protein-A levels in patients with newly diagnosed idiopathic pulmonary fibrosis. Chest 125 (2004) 617-625
23. Doyle I.R., Bersten A.D., and Nicholas T.E. Surfactant proteins-A and -B are elevated in plasma of patients with acute respiratory failure. Am J Respir Crit Care Med 156 (1997) 1217-1229
24. Horiuchi T., Mason J.R., Kuroki Y., and Cherniack R.M. Surface and tissue forces, surfactant protein A, and the phospholipid components of pulmonary surfactant in bleomycin-induced pulmonary fibrosis in the rat. Am Rev Respir Dis 141 (1990) 1006-1013
25. Savani R.C., Godinez R.I., Godinez M.H., Wentz E., Zaman A., Cui Z., et al. Respiratory distress after intratracheal bleomycin: selective deficiency of surfactant proteins B and C. Am J Physiol Lung Cell Mol Physiol 281 (2001) 685-696
26. Pan T., Nielsen L.D., Allen M.J., Shannon K.M., Shannon J.M., Selman M., et al. Serum SP-D is a marker of lung injury in rats. Am J Physiol Lung Cell Mol Physiol 282 (2002) L824-L832
27. Doyle I.R., Nicholas T.E., and Bersten A.D. Serum surfactant protein-A levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome. Am J Respir Crit Care Med 152 (1995) 307-317
28. Hermans C., Dong P., Robin M., Jadoul M., Bernard A., Bersten A.D., et al. Determinants of serum levels of surfactant proteins A and B and Clara cell protein CC16. Biomarkers 8 (2003) 461-471